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Abstract Chronic inflammation is a major risk factor
underlying aging and the associated diseases of aging; of
particular interest is insulin resistance during aging.
Chronic inflammation impairs normal lipid accumulation,
adipose tissue function, mitochondrial function, and causes
endoplasmic reticulum (ER) stress, which lead to insulin
resistance. However, some studies show that insulin
resistance itself amplifies chronic inflammation. The
activity of the insulin-dependent Akt signaling pathway is
highlighted because of its decrease in insulin-sensitive
organs, like liver and muscle, which may underlie insulin
resistance and hyperinsulinemia, and its increased levels in
non-metabolic organs, such as kidney and aorta. In that the
prevalence of obesity has increased substantially for all age
groups in recent years, our review summarizes the data
showing the involvement of chronic inflammation in
obesity-induced insulin resistance, which perpetuates
reciprocal interactions between the chronic inflammatory
process and increased adiposity, thereby accelerating the
aging process.
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Introduction
Chronic, low-grade, systemic inflammation is wildly
accepted as a significant risk factor underlying aging and
major diseases (Yu and Chung 2006). Inflammation, as
part of the key innate immune defense system, is an
essential protective mechanism that fights against not only
invading pathogens and other exogenous harmful materi-
als, but also endogenously produced substances (Mogen-
sen 2009) that are tightly regulated under normal
conditions. However, unresolved chronic inflammation is
known to exacerbate and underlie age-related diseases
such as cancer, type 2 diabetes, cardiovascular diseases,
arthritis, osteoporosis, and Alzheimer’s disease (Howcroft
et al. 2013).
Strong evidence was presented on a plausible relation-
ship between inflammation and obesity-related diseases
(Gregor and Hotamisligil 2011). It was shown that an age-
related increase in visceral adiposity results in high circu-
lating levels of pro-inflammatory cytokines that interfere
with insulin signaling during the aging process (Sepe et al.
2011). Pro-inflammatory macrophages, a major source of
cytokines, are present in much higher numbers in the
adipose tissue of obese subjects than lean subjects (Heil-
bronn and Campbell 2008).
Pro-inflammatory cytokines were shown to act in an
autocrine or paracrine manner to induce insulin resistance
in peripheral tissues and macrophages (Schenk et al. 2008;
Tilg and Moschen 2008). The effect of pro-inflammatory
cytokines that induces insulin resistance begins by the
ameliorated tyrosine phosphorylation of insulin receptor
substrate (IRS)-1.
In this review, we summarize recent work on the close
association between chronic inflammation and insulin
resistance during aging process.
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Molecular insights into the inflammatory process
during aging
In chronic inflammation, the inflammatory response is
driven by the versatile transcription factor, nuclear factor-
jB (NF-jB) during aging. NF-jB is activated by the IjB
kinase (IKK)/NF-jB inducing kinase (NIK) and the mito-
gen activated protein kinase (MAPK) pathways (Fig. 1).
Once activated, NF-jB promotes the expression of several
other pro-inflammatory cellular mediators, like prosta-
glandins (PGs), inducible nitric oxide synthase (iNOS), and
inflammation-related cytokines. PG metabolites are pro-
duced by the action of the enzyme, cyclooxygenase (COX).
These are important pro-inflammatory mediators that are
known to increase reactive oxygen species (ROS) pro-
duction, which leads to DNA and tissue damage (Yu and
Chung 2001). PGs-induced ROS generation steadily
increases in peripheral tissue during aging (Chung et al.
2011). Several studies using COX-2 deficient mice reveal
impaired inflammatory responses through the attenuation
of PGs generation (Morham et al. 1995; Dinchuk et al.
1995). Not only ROS but also pro-inflammatory cytokines
such as interleukin (IL)-1b and IL-6 are enhanced by PGs
(Aoki and Narumiya 2012). Nitric oxide (NO) is one of the
most physiologically important radical species known to
induce the chronic inflammatory response. NO is synthe-
sized by iNOS and can cause pathogenesis and destruction
of various tissues, similar to that seen in chronic inflam-
matory (Zamora et al. 2000).
The recently established inflammasome, an essential
component of the innate immune response, plays a key role
in the inflammatory process by the secretion of the cyto-
kines, IL-1b and IL-18 (Agostini et al. 2004). The close
cooperative actions between the inflammasome and NF-jB
undoubtedly exacerbates the chronic inflammatory status
during the aging process (Howcroft et al. 2013). The most
studied NLRP3 inflammasome is an intracellular protein
complex composed of NOD-like receptor (NLR) proteins,
apoptosis-associated speck-like protein containing a CARD
(ASC), and pro-caspase-1, which result in caspase-1 acti-
vation. The formation of the inflammasome induces auto-
processing and activation of caspase-1 leading to the pro-
cessing of cellular substrates, namely IL-1b and IL-18.
Activation of the well-studied NLRP3 inflammasome has a
diverse sensing ability reported to participate in aging-
related inflammatory processes. It is worth noting the
recent important report by Youm et al in which the authors
describe that the suppression of the NLRP3 inflammasome
extended the healthy lifespan of mice by attenuating age-
related degenerative changes, including cognitive decline.
Based on their findings, the authors proposed that sup-
pression of aberrant NLRP3 activity during aging may well
attenuate age-related diseases by reducing chronic inflam-
mation (Youm et al. 2013).
Insulin resistance and altered PI3K/Akt signaling
pathway
Through mechanistic exploration, numerous studies have
produced various interesting data, but to date, there seems
to be no unifying consensus, implying the complex nature
of the subject (Muoio and Newgard 2008; Kahn et al. 2006;
Saini 2010). One interesting observations is that insulin
resistance, at cellular and molecular levels, is characterized
by dysfunction in the IRS/phosphoinositide 3-kinase
(PI3K)/Akt signaling pathway, which results in impaired





























Fig. 1 Signaling pathways
downstream of NIK and Akt
activation. Extracellular
receptors bind to their ligands
and signal via NF-jB inducing
kinase (NIK) or Akt molecules.
This leads to phosphorylation of
the IjB kinase (IKK) subunits
and the subsequent
phosphorylation of IjBa, which




nuclear factor-jB (NF-jB) and
Interleukin-1b (IL-1b). NF-jB
is then released into the nucleus
where it acts as a transcription
factor and stimulates
inflammatory responses
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involved in glucose uptake has a series of sequential events
beginning at the insulin receptor (IR), which is a hetero-
tetramer consisting of two a subunits and two b subunits
that are linked by disulfide bonds. Insulin binds to the a
subunit of the IR and activates the tyrosine kinase in the b
subunits to initiate insulin signaling. Once the tyrosine
kinase of the IR is activated, it promotes auto-phosphory-
lation of the b subunit, where phosphorylation of tyrosine
residues and a conformational change are required to
amplify the kinase activity. The activated receptor then
phosphorylates adaptor molecules, such as IRS-1 and IRS-
2, which permit the recruitment and activation of phos-
phatidylinositol 3-kinase (PI3-kinase). Activated PI3-
kinase produces 3-phosphoinositides, phosphatidyl-inosi-
tol-3,4-bisphosphate (PIP2) and phosphatidyl-inositil-
3,4,5-trisphosphate (PIP3) that bind to phosphoinositide-
dependent kinase 1 (PDK1). Akt activates glucose trans-
porter 4 (GLUT4), which moves to the cell surface to
transport glucose into the cell.
Possible causes underlying insulin resistance through
inflammation activation during aging
Lipid accumulation
Lipids have a wide variety of roles in biological systems.
These roles are a consequence of their chemical and physical
properties. However, excess lipid accumulation induces
insulin resistance during aging. Recently studies have shown
that inflammatory responses disrupt normal lipid accumu-
lation. For example, pro-inflammatory cytokines such as IL-
6 and tumor necrosis factor-a (TNFa) impair the lipid
accumulation by promoting WNT signaling (Gustafson and
Smith 2006). Indeed, inflammation leads to lipid accumu-
lation through disruption of the expression of proteins related
to lipid metabolism, such as sterol regulatory element
binding protein (SREBP), a basic helix-loop-helix tran-
scription factor that controls the expression of genes required
for cholesterol, fatty acids, triglycerides and phospholipids
synthesis (Ferre and Foufelle 2007).
A recent cDNA microarray study from our laboratory
(Park et al. 2013) documented that the genes upregulated
during aging contain several major inflammatory genes.
The upregulated genes included NF-jB1alpha and a
90 kDa ribosomal protein, S6 kinase, which is related to
mammalian target of rapamycin (mTOR) in aged rats (Park
et al. 2013). In the aging transcriptome, genes that are
related to both the immune response and to inflammation
were upregulated with age, particularly those related to
cytokine–cytokine receptor interaction, natural killer cell
mediated cytotoxicity, and primary immunodeficiency
(Anderson et al. 2010). Down-regulated genes, such as
peroxisome proliferator-activated receptors (PPARs) asso-
ciated with lipid metabolism, were also observed with
aging according to the gene ontology data (Hong et al.
2010). Similarly, energy metabolism, insulin signaling, and
PPAR signaling genes were down-regulated, as shown by
the analysis of the protein–protein interaction network that
was composed of genes differentially expressed during
aging (Park et al. 2013). The involvement of inflammation
was also shown by the reduction of ABCA1-mediated
cholesterol efflux that was regulated by PPARs in accel-
eration of foam cell formation through disrupting LDL
receptors-mediated negative feedback regulation in vas-
cular smooth muscle cells and mesangial cells (Ma et al.
2008). These data further support that metabolic disorders
associated with lipid accumulation are closely related to
chronic inflammation at the molecular level during aging.
Dysregulated adipose tissue
White adipose tissue (WAT) not only is involved in energy
storage in the body, but also secretes a variety of bioactive
molecules including adiponectin, IL-1b, IL-6, and TNFa,
which enable the adipose tissue to communicate with other
tissues and organs, such as the liver, skeletal muscle, and
central nervous system. Through this interaction network,
WAT participates in regulating important biological pro-
cesses, such as food intake, energy homeostasis, and
insulin resistance. Adipose tissue is at the nexus of mech-
anisms and signaling pathways involved in metabolic dis-
order, inflammation, aging and age-related diseases.
Obesity and aging are affected by increasing both the size
and number of adipocytes. Adipogenesis can lead to a large
number of new adipocytes (i.e., hyperplasia), which pro-
duce more adiponectin and fewer pro-inflammatory adi-
pokines. In contrast, the prevalence of hypertrophied
adipocytes in adipose tissue encourages increased macro-
phage infiltration (Despres 2006; Goossens 2008). The
recruitment of macrophages into adipose tissue is the initial
event leading to obesity-induced inflammation and insulin
resistance (Fig. 2).
In general, over-nutrition and aging cause adipocytes to
secrete chemokines, such as pro-inflammatory monocyte
chemotactic protein-1 (MCP-1) and others that provide a
chemotactic gradient that attracts monocytes to the adipose
tissue where they become adipose tissue macrophages
(ATMs). Once pro-inflammatory ATMs migrate into adi-
pose tissue, they also secrete their own chemokines, which
attract additional macrophages creating a feed-forward
inflammatory process (Olefsky and Glass 2010). Thus,
ATMs perpetuate inflammation, by inducing local and sys-
temic increases of pro-inflammatory molecules like IFNc,
IL-1b, IL-6, and TNFa, while decreasing other adipokines,
such as adiponectin.
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Hypertrophied adipocytes, which are up to 150–200 lm
in diameter are larger than the normal distance that O2 can
diffuse, which is 100–200 lm (Skurk et al. 2007; Brahimi-
Horn and Pouyssegur 2007), which leads to a hypoxic
condition. Hypoxia in obese adipose tissue has been well
characterized by many researchers, and so has the induc-
tion of a key regulator, hypoxia-inducible factor-1 (HIF-1)
(Hosogai et al. 2007; Wang 2007). HIF-1 is a transcription
factor that accumulates during hypoxia and increases the
mRNA expression of a wide variety of genes that stimulate
erythropoiesis, angiogenesis, and glycolysis (Semenza
2000). Thus, it provides a major link to the pathogenesis of
insulin resistance (Olefsky and Glass 2010).
Visceral adipose tissue refers to intra-abdominal fat
around the intestines and it correlates with liver fat. Vis-
ceral adipose tissue has metabolic characteristics that differ
from those of subcutaneous fat. It is more metabolically
active with a high free fatty acid (FFA) turnover, and the
increased flux of FFAs promotes insulin resistance at a
cellular level and increases hepatic very low density lipo-
protein (VLDL) production. Indeed, excess visceral adi-
posity has been shown to accompany chronic low-grade
inflammation (Giorgino et al. 2005). Studies on the visceral
adipose tissue from lean or obese subjects demonstrate that
macrophage specific markers and chemokines involved in
monocyte chemotaxis, as well as their receptors, are ele-
vated in obese visceral fat compared with lean controls
(Huber et al. 2008).
Mitochondrial dysfunction
For many years, it has been known that mitochondrial
dysfunction is associated with type 2 diabetes mellitus
(T2DM) and age-related insulin resistance (Stump et al.
2003; Petersen et al. 2003). The mitochondrial oxidative
phosphorylation capacity is defined as the maximal ADP-
stimulated oxidative phosphorylation elicited by a high
ADP:ATP ratio that reflects the maximal energy demands
of the cell at saturating concentrations of substrates
(Chance et al. 2006; Prompers et al. 2006). Mitochondrial
oxidative phosphorylation and unlimited oxygen supply is
very important for the function of the cell. However, sub-
jects with T2DM, often have mitochondrial dysfunctions
such as reduced insulin-stimulated ATP production, lower
protein expression of respiratory chain subunits, decreased
mitochondrial DNA, and decreased mitochondrial size and
density (Ritov et al. 2005; Heilbronn et al. 2007; Szendr-
oedi et al. 2007; Hwang et al. 2010).
In addition, several studies have shown that the oxida-
tive phosphorylation capacity is impaired in muscle biopsy
samples from patients with T2DM compared with healthy
individuals (Phielix et al. 2008; Boushel et al. 2007).
Moreover, the expression of genes for mitochondrial oxi-
dative phosphorylation is related to insulin resistance
(Petersen et al. 2003). Mitochondrial dysfunction results in
the accumulation of fatty acid metabolites, diacylglycerol
(DAG), and long chain fatty acyl-CoA (Itani et al. 2002)
causes decreased fatty acid oxidation. Intracellular accu-
mulation of DAG activates protein kinase C (PKC), which
in turn activates IKK and JNK leading to increased serine
phosphorylation of IRS, and consequently attenuation of
insulin signaling (Griffin et al. 1999; Yu et al. 2002).
Indeed, with aging, mutations and deletions occur in
mtDNA, leading to impaired function of the respiratory
chain and enhanced ROS production (Chomyn and Attardi
2003). Thus, mitochondrial dysfunction is highly likely one
of the major causes of the age-related chronic
inflammation.
Fig. 2 Obesity is determined by increasing both, the size and number
of adipocytes. Adipogenesis can lead to a large number of new
adipocytes (hyperplasia) which produce more adiponectin and less
inflammatory adipokines. Conversely, hypertrophied adipocytes pro-
duce less adiponectin and more inflammatory adipokines. The
prevalence of hypertrophied adipocytes in adipose tissue leads to a
reduction in blood flow with subsequent hypoxia and macrophage
infiltration. In addition, cytokines produced by macrophages inhibit
adipogenesis
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ER stress
Endoplasmic reticulum (ER) is an organelle that is com-
prised of a reticular membranous network that extends
throughout the cytoplasm and is contiguous with the
nuclear envelope. This organelle is involved in several
important cellular functions that affect the homeostasis of
the whole-organism. The ER is also the cellular site where
all secretory and integral membrane proteins are folded and
post-translationally modified in an ATP dependent process
mediated by chaperones, which allows the cell to respond
to misfolded proteins within the ER. These pathways are
collectively known as the unfolded protein response (UPR)
and are important for normal cellular homeostasis and
organismal development, and may play key roles in the
pathogenesis of many diseases. In addition, the ER is also a
site of Ca2? storage and biosynthesis for steroids, choles-
terol, and lipids (van Meer et al. 2008; Ron and Walter
2007).
Recently studies demonstrated that fatty acid overload
rapidly induces ER stress in pancreatic b cells and hepa-
tocytes that leads to impaired insulin secretion and lucose
uptake, respectively (Borradaile et al. 2006; Kharroubi
et al. 2004). Recent studies also suggest that ER stress
plays an important role in the onset of obesity, insulin
resistance, and T2DM (Wellen and Hotamisligil 2005;
Eizirik et al. 2008; Ozawa et al. 2005). ER stress in
hepatocytes and adipocytes contributes to insulin resis-
tance, in part through IRE1-dependent, JNK mediated
inhibition of IRS-1 tyrosine phosphorylation, and increased
serine phosphorylation (Ozawa et al. 2005; Hirosumi et al.
2002). Several chaperones and folding enzymes such as
glucose regulated proteins 78 (GRP78; which is also
known as immunoglobulin binding protein [BiP]), protein
disulfide isomerase (PDI), calnexin, and calreticulin par-
ticipate in protein folding in the ER. These chaperones and
foldases decrease with age (Naidoo et al. 2005; Nuss et al.
2008; Rabek et al. 2003).
ER stress has been demonstrated to trigger activation of
JNK as well as IKK by increasing IRE1 and leads to
inducing NF-jB activation (Brown et al. 2008). Increased
JNK and NF-jB signaling would then induce the expres-
sion of pro-inflammatory cytokines (Hirosumi et al. 2002).
ER stress is also a major source of ROS generation due to
Ca2?release. This increases the concentration of cytosolic
Ca2? and subsequently stimulates mitochondria metabo-
lism to produces more ROS. Thus, the ER may be a
proximal site that senses over-nutrition and translates it
into metabolic and age-related inflammatory responses.
Interdependency between inflammation and insulin
resistance during aging
Although many studies have focused on the effects of
inflammatory responses on insulin resistance, only few
studies have specifically investigated the effects of insulin
resistance on inflammatory responses. Exposure to exces-
sive amounts of nutrients and energy can impair the insulin
signaling in metabolically important tissues such as the
liver, adipose tissue, and skeletal muscle. Insulin resistance
is therefore closely associated with chronic inflammation,
likely due to increased levels of pro-inflammatory
cytokines.
In fact, type 2 diabetes induced by insulin resistance has
recently been suggested as a cause of accelerated aging
(Mokdad et al. 2001). In an insulin resistant state, serum
insulin levels are increased to a hyperinsulinemia state that
activates the Akt/IKK signaling pathway, and thus activates
NF-jB, a core transcription factor involved in the inflam-
matory response in non-metabolic organs (Fig. 3). Over
recent years, the incidence of NF-jB activation in human
kidney has risen dramatically, primarily because of the
increasing prevalence of both obesity and insulin resistance
(El-Atat et al. 2004). Obesity and insulin resistance
both make substantial contributions to renal disease by
Fig. 3 Crosstalk between
insulin resistance in metabolic
organs and molecular
inflammation in non-metabolic
organs. The serum insulin
concentration is up regulated in
an insulin resistance state.
Insulin resistance-induced
hyperinsulinemia stimulates
inflammatory responses in non-
metabolic organs such as kidney
by activating the Akt/IjB kinase
(IKK) signaling pathway
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up-regulating Akt activity. Many studies suggest that
chronic insulin resistance, accompanied by hyperinsuline-
mia, contributes to several pathologies, such as atheroscle-
rosis, through augmenting the effects of pro-inflammatory
cytokines (Lele 2007; Goldschmidt-Clermont et al. 2005). In
practice, high levels of the pro-inflammatory cytokines have
been found in the adipose tissue of a diabetic rat model. They
activate JNK and IKK/NF-jB signaling pathways, resulting
in or from the up-regulation of potential mediators of
chronic inflammation, which perpetuates reciprocal inter-
actions between the chronic inflammation and adiposity,
leading to accelerated aging.
Therefore, it is possible that therapeutic drugs for insulin
resistance, such as AMPK activator or PPARa/c dual
agonist, have the potential to become anti-aging agents by
ameliorating insulin resistance. Actually, metformin, an
AMPK activator, extends lifespan in C. elegansand mice
(Cabreiro et al. 2013; Martin-Montalvo et al. 2013).
Indeed, it has been shown that insulin-induced FOXO1 is a
master protein that turns on the expression of another key
inflammatory cytokine, IL-1b that also inhibits insulin
signaling (Su et al. 2009). Thus, FOXO1 inhibitors may
have the potential to develop into anti-aging agents through
their ability to inhibit IL-1b production.
It is still unclear whether insulin resistance or inflam-
mation occurs first. It is clear however, that there is a
vicious cycle between insulin resistance and inflammation
that occurs during aging and contributes to accelerated
aging. Also, over-nutrition intake, such as with a western
diet, could accelerate aging by increasing both inflamma-
tion and insulin resistance.
Conclusion
Many aging hypotheses have been proposed over the past
several decades, including the recent molecular inflam-
mation hypothesis of aging. This hypothesis of molecular
inflammation is based on activities of the key NF-jB sig-
naling pathway, which plays a crucial role in activating the
systemic inflammatory response during the aging process
when there is increased adiposity. Chronic inflammation
due to obesity-induced ectopic tissue, such as liver and
muscle lipid accumulation further exacerbates insulin
resistance. A state of chronic inflammation perpetuates an
insulin resistant state, and the interactions between a
chronic inflammatory response and increased adiposity
likely accelerate the aging process.
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